These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 3621151)

  • 21. Investigations on the mechanisms of methotrexate resistance in a cisplatin-resistant L1210 murine leukemia cell subline.
    Wroblewski DH; Bhushan A; Xuan Y; Brinton BT; Tritton TR; Hacker MP
    Cancer Chemother Pharmacol; 1996; 37(4):337-42. PubMed ID: 8548879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
    Yoshida M; Khokhar AR; Siddik ZH
    Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR; Kaufmann WK; Chaney SG
    Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin resistance in a murine leukemia cell line is associated with a defective apoptotic process.
    Segal-Bendirdjian E; Jacquemin-Sablon A
    Exp Cell Res; 1995 May; 218(1):201-12. PubMed ID: 7537690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG
    Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of various mRNA potentially involved in cisplatin resistance of murine leukemia L1210 cells.
    Sheibani N; Eastman A
    Cancer Lett; 1990 Jul; 52(3):179-85. PubMed ID: 1974166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deficient apoptotic process in cisplatin-resistant L1210 cells cannot account for the cellular response to various drug treatments.
    Canitrot Y; Frit P; Salles B
    Biochem Biophys Res Commun; 1997 May; 234(3):573-7. PubMed ID: 9175754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.
    Richon VM; Schulte N; Eastman A
    Cancer Res; 1987 Apr; 47(8):2056-61. PubMed ID: 3828995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M; Khokhar AR; Siddik ZH
    Cancer Res; 1994 Sep; 54(17):4691-7. PubMed ID: 8062266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.
    Jennerwein MM; Eastman A; Khokhar AR
    Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross resistance studies with L1210 leukemia subline single and double resistant to cisplatin and iproplatin (CHIP).
    Hrubisko M; Ujházy V
    Neoplasma; 1990; 37(6):631-8. PubMed ID: 2274083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Murine leukemia L1210 cell lines with different patterns of resistance to platinum coordination complexes.
    Eastman A; Illenye S
    Cancer Treat Rep; 1984 Sep; 68(9):1189-90. PubMed ID: 6541096
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of altered tyrosine phosphorylation with methotrexate resistance in a cisplatin-resistant subline of L1210 cells.
    Bhushan A; Wroblewski D; Xuan Y; Tritton TR; Hacker MP
    Biochem Pharmacol; 1996 Feb; 51(4):477-82. PubMed ID: 8619893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
    Johnston HP; Hawley P; White SE; Gibson I; Tidd DM
    Br J Cancer; 1985 Apr; 51(4):505-14. PubMed ID: 3838480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-benzyladriamycin-14-valerate versus progressively doxorubicin-resistant murine tumours: cellular pharmacology and characterisation of cross-resistance in vitro and in vivo.
    Ganapathi R; Grabowski D; Sweatman TW; Seshadri R; Israel M
    Br J Cancer; 1989 Dec; 60(6):819-26. PubMed ID: 2605093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of verapamil on the uptake and efflux of etoposide (VP16) in both sensitive and resistant cancer cells.
    Feng MR; Liebert M; Wedemeyer G; Grossman HB; Mancini WR; Williams M; Wagner JG
    Sel Cancer Ther; 1991; 7(2):75-83. PubMed ID: 1754730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cisplatin efflux, binding and intracellular pH in the HTB56 human lung adenocarcinoma cell line and the E-8/0.7 cisplatin-resistant variant.
    Chau Q; Stewart DJ
    Cancer Chemother Pharmacol; 1999; 44(3):193-202. PubMed ID: 10453720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting anti-neoplastic agents.
    Tagliabue G; Pifferi A; Balconi G; Mascellani E; Geroni C; D'Incalci M; Ubezio P
    Int J Cancer; 1993 May; 54(3):435-42. PubMed ID: 8509218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposed mechanism of therapeutic selectivity for 9-beta-D-arabinofuranosyl-2-fluoroadenine against murine leukemia based upon lower capacities for transport and phosphorylation in proliferative intestinal epithelium compared to tumor cells.
    Barrueco JR; Jacobsen DM; Chang CH; Brockman RW; Sirotnak FM
    Cancer Res; 1987 Feb; 47(3):700-6. PubMed ID: 3802076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.